Quarterly Activities/Appendix 4C Cash Flow Report
Filed with ASX · · 9 pages · English
Earlier from Resonance Health
- AGM Presentation
- Investor Strategy Day Presentation
- FY25 Full Year Results & FY26 Guidance Investor Presentation
- Appendix 4E & Full Year Statutory Accounts
- TrialsWest Expands with New Clinical Trial Site
Later from Resonance Health
- Half Year Report & Accounts
- Half Year Results
- Half Year Results Presentation
- Receipt of R&D Tax Incentive Refund
- Profit Guidance Upgrade
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health